Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. reported a net loss of $303.3 million for fiscal year 2025, with no collaboration revenue. The company incurred significant operating expenses totaling $326.2 million, primarily driven by research and development costs of $267.1 million and general and administrative expenses of $59.1 million. Other income of $22.9 million partially offset the operating loss. The company's balance sheet...